The Swiss Competition Authority carries out a dawn raid which causes a pharmaceutical company to drop IP infringement court actions against a competitor (Novartis / Lily)

Pregno, Giovanni; Longeval, Catherine; L'Ecluse, Peter; T'Syen, Koen

Previous article The Hong Kong Competition Authority brings its first case to the Competition Tribunal for resale price maintenance (Tien Chu) Next article The EU General Court confirms Android abuse of dominance through tying, with the real legacy of the case extending far beyond (Google Android)

15 Sep 2022

The Swiss Competition Authority carries out a dawn raid which causes a pharmaceutical company to drop IP infringement court actions against a competitor (Novartis / Lily)

KEYWORDS

Reference

Swiss Competition Authority, Novartis / Lily, Press release, 15 September 2022

As we have previously reported (Van Bael & Bellis Life Sciences News and Insights, 15 September 2022), on 13 September 2022, the Swiss Competition Authority carried out an inspection at the premises of Novartis Pharma AG ( Novartis ). In parallel, Novartis received a request for

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Authors

Giovanni Pregno
Van Bael & Bellis (Brussels)

Belgium 18 contributions 2961 visits
Catherine Longeval
Van Bael & Bellis (Brussels)

Belgium 45 contributions 22005 visits
Peter L’Ecluse
Van Bael & Bellis (Brussels)

Belgium 141 contributions 47831 visits
Koen T’Syen
Van Bael & Bellis (Brussels)

Belgium 44 contributions 21140 visits

Quotation

Giovanni Pregno, Catherine Longeval, Peter L'Ecluse, Koen T'Syen, The Swiss Competition Authority carries out a dawn raid which causes a pharmaceutical company to drop IP infringement court actions against a competitor (Novartis / Lily), 15 September 2022, e-Competitions September 2022, Art. N° 109532

Visites 169